Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs104894031
rs104894031
0.800 GeneticVariation UNIPROT Substitution of isoleucine for threonine at position 190 of S-opsin causes S-cone-function abnormalities. 23022137

2012

dbSNP: rs104894032
rs104894032
0.800 GeneticVariation UNIPROT Substitution of isoleucine for threonine at position 190 of S-opsin causes S-cone-function abnormalities. 23022137

2012

dbSNP: rs104894033
rs104894033
0.800 GeneticVariation UNIPROT Substitution of isoleucine for threonine at position 190 of S-opsin causes S-cone-function abnormalities. 23022137

2012

dbSNP: rs104894031
rs104894031
0.800 GeneticVariation UNIPROT Human tritanopia associated with a third amino acid substitution in the blue-sensitive visual pigment. 1386496

1992

dbSNP: rs104894031
rs104894031
0.800 GeneticVariation UNIPROT Human tritanopia associated with two amino acid substitutions in the blue-sensitive opsin. 1531728

1992

dbSNP: rs104894032
rs104894032
0.800 GeneticVariation UNIPROT Human tritanopia associated with a third amino acid substitution in the blue-sensitive visual pigment. 1386496

1992

dbSNP: rs104894032
rs104894032
0.800 GeneticVariation UNIPROT Human tritanopia associated with two amino acid substitutions in the blue-sensitive opsin. 1531728

1992

dbSNP: rs104894033
rs104894033
0.800 GeneticVariation UNIPROT Human tritanopia associated with a third amino acid substitution in the blue-sensitive visual pigment. 1386496

1992

dbSNP: rs104894033
rs104894033
0.800 GeneticVariation UNIPROT Human tritanopia associated with two amino acid substitutions in the blue-sensitive opsin. 1531728

1992

dbSNP: rs104894031
rs104894031
T 0.800 CausalMutation CLINVAR

dbSNP: rs104894032
rs104894032
G 0.800 CausalMutation CLINVAR

dbSNP: rs104894033
rs104894033
A 0.800 CausalMutation CLINVAR

dbSNP: rs1190183515
rs1190183515
0.700 GeneticVariation UNIPROT

dbSNP: rs1801394
rs1801394
0.010 GeneticVariation BEFREE The possible interaction between folic acid supplementation and MTRR 66A>G, if confirmed, would strengthen evidence for prepregnancy folate protection against CBT. 25809864

2015

dbSNP: rs11203289
rs11203289
0.010 GeneticVariation BEFREE The proband with unilateral CBT had a germline SDHC c.3G>A (p.M1I) mutation. 22351710

2012

dbSNP: rs1131691061
rs1131691061
0.010 GeneticVariation BEFREE The proband with unilateral CBT had a germline SDHC c.3G>A (p.M1I) mutation. 22351710

2012

dbSNP: rs1398198098
rs1398198098
0.010 GeneticVariation BEFREE The proband with unilateral CBT had a germline SDHC c.3G>A (p.M1I) mutation. 22351710

2012

dbSNP: rs587776652
rs587776652
0.010 GeneticVariation BEFREE The proband with unilateral CBT had a germline SDHC c.3G>A (p.M1I) mutation. 22351710

2012

dbSNP: rs80338842
rs80338842
0.010 GeneticVariation BEFREE The proband with unilateral CBT had a germline SDHC c.3G>A (p.M1I) mutation. 22351710

2012

dbSNP: rs878854590
rs878854590
0.010 GeneticVariation BEFREE The proband with unilateral CBT had a germline SDHC c.3G>A (p.M1I) mutation. 22351710

2012

dbSNP: rs662
rs662
0.010 GeneticVariation BEFREE The Q192R polymorphism, which alters the structure of PON1 and influences enzyme activity in a substrate-dependent manner, was not associated with CBT risk, nor was the PON1(C-108T/Q192R) haplotype. 16002382

2005